Putting protein motion at the heart of drug discovery to expand therapeutic possibilities51-200 Employees
- B2B
- Public StagePublicly traded company
- Top InvestorsThis company has received a significant amount of investment from top investors
- 5.0Highly ratedRelay Therapeutics is highly rated on Glassdoor, with 5.0 out of 5 stars
- 4.8Work / Life BalanceEmployees rate Relay Therapeutics 4.8/5 on Glassdoor for work / life balance
- 5.0Strong LeadershipEmployees rate Relay Therapeutics 5.0/5 on Glassdoor for faith in leadership
Relay Therapeutics Funding
$0
33 rounds
Relay Therapeutics is active in the following markets / industries: biotechnology, health care, therapeutics, technology and Science. The company has secured funding across 3 rounds and is valued at $0. Their most recent funding was raised on December 20, 2018.
Funding Rounds
C
$400000000A
$57000000B
$63000000Investors of Relay Therapeutics
Third Rock Ventures
Funds and builds life science companies with high growth potential
Rounds
A